Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England Journal of Medicine.

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

Additionally, the Department of Health and Human Services unveiled the framework for the Most Favored Nation drug pricing ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit ...

The Food and Drug Administration (FDA) will require more evidence for what top officials describe as the uniquely American ...

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

Shares of Moderna surged to lead S&P 500 gainers Tuesday after the Food and Drug Administration issued new guidance for COVID ...

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for approvals in ...